News for Twist Bioscience Corporation (TWST)

Summary Twist Bioscience Corp (TWST), a prominent player in the life sciences sector, announced on [date of press release] the granting of 70,254 equity awards

Twist Bioscience posted 23% year-over-year sales growth and beat EPS expectations in its most recent quarter. Click here to read an analysis of TWST stock now.

Twist Bioscience Corporation (NASDAQ: TWST), a core mid-cap growth and value equity company in the life sciences segment of the health care sector, today annou

Twist Bioscience Corporation (TWST) to release Q3 fiscal 2025 financial results on August 4, 2025. Company to host a live webcast and conference call at

[url="]Twist Bioscience Corporation[/url] (NASDAQ: TWST), a core mid-cap growth and value equity company in the life sciences segment of the health care sector

Twist Bioscience Corporation (NASDAQ:TWST) is among the 11 Best Genomics Stocks to Buy According to Hedge Funds. The firm has expanded its relationship with Element Biosciences to produce end-to-end Next Generation Sequencing (NGS) solutions. Twist Bioscience Corporation (NASDAQ:TWST)’s library prep and target enrichment workflows are now integrated with Element’s AVITI™ devices and Trinity™ flowcells. Twist […]

Cathie Wood underscored the application of AI in the healthcare sector by sharing new research by Mass General Brigham.

[url="]Twist Bioscience Corporation[/url] (NASDAQ: TWST), a core mid-cap growth and value equity company in the life sciences segment of the health care sector

Twist Bioscience Corporation (NASDAQ: TWST), a core mid-cap growth and value equity company in the life sciences segment of the health care sector, today annou

Cathie Wood highlights the rising applications of AI and how it is poised to impact the health care space.

We recently published an article titled Billionaire Nicholas J.

We recently published an article titled Billionaire Nicholas J. Pritzker’s 8 Stocks with Huge Upside Potential. In this article, we are going to take a look at where Twist Bioscience Corporation (NASDAQ:TWST) stands against Nicholas J. Pritzker’s other stock picks with huge upside potential. Nicholas J. Pritzker is the chairman and co-founder of Tao Capital Partners, […]

Twist Bioscience and Ginkgo Bioworks revise their agreement, securing a $15M deal. Read more here.

Twist Bioscience's downbeat tone on the earnings call suggest there are challenges ahead. Read why it is difficult to argue TWST stock is meaningfully undervalued.

On May 6, 2025, leading financial services company Goldman Sachs made adjustments to its assessment of Twist Bioscience (TWST), reaffirming the "Buy" rating but

On May 6, 2025, Guggenheim analyst Subbu Nambi reaffirmed his positive outlook on Twist Bioscience (TWST), maintaining a "Buy" rating on the stock. The price ta

Twist Bioscience Corporation (NASDAQ:TWST) Q2 2025 Earnings Call Transcript May 5, 2025Twist Bioscience Corporation misses on earnings expectations.

Key Takeaways: Twist Bioscience has launched Atlas Data Storage with significant backing, demonstrating strategic growth initiatives. The company shows s

Discover Twist Bioscience's Q2 2025 earnings insights, including 23% revenue growth, gross margin gains, and strategic developments like the Atlas Data...